/SKYI

SKYI Stock - Sky Century Investment, Inc.

Q: What is the analyst price target for SKYI?

Analyst price target information is not currently available for SKYI.

Q: What is SKYI's market cap?

Market capitalization information is not currently available for SKYI.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Jan 12

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SKYI

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

FY2025

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.15

52W High$0.01

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$76,338	$30,900	$74,760	$61,000	$76,757
Gross Profit	$24,479	$-68,725	$-8,052	$-5,000	$68,470
Gross Margin	32.1%	-222.4%	-10.8%	-8.2%	89.2%
Operating Income	$-116,631	$-172,409	$-193,620	$-215,420	$-5,330
Net Income	$-117,225	$-172,409	$-193,617	$-212,246	$-5,327
Net Margin	-153.6%	-558.0%	-259.0%	-347.9%	-6.9%
EPS	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00

Company Overview

Sky Century Investment, Inc. engages in selling cannabidiol products using pharmaceutical grade ingredients. The company also provides a range of online services in the field of digital marketing, strategy, planning, SEO, analytics, and reporting. In addition, it is involved in the provision of content and website development, and mail marketing services for companies involved in the production of CBD products. The company was incorporated in 2012 and is based in Las Vegas, Nevada.

Visit Website

Earnings History & Surprises

SKYI

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.00

Q4 2023

EPS Surprise History

Q4 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2023	Nov 30, 2023	—	$-0.00	—	—

Frequently Asked Questions about SKYI

What is SKYI's current stock price?

Sky Century Investment, Inc. (SKYI) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for SKYI?

No analyst price targets are currently available for this stock.

What sector is Sky Century Investment, Inc. in?

Sky Century Investment, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is SKYI's market cap?

Sky Century Investment, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does SKYI pay dividends?

No, Sky Century Investment, Inc. does not currently pay a dividend to shareholders.